Net Loss of Vivimed Labs reported to Rs 16.05 crore in the quarter ended December 2023 as against net loss of Rs 18.31 crore during the previous quarter ended December 2022. Sales declined 25.62% to Rs 41.46 crore in the quarter ended December 2023 as against Rs 55.74 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales41.4655.74 -26 OPM %3.06-9.20 - PBDT-11.90-14.30 17 PBT-16.60-18.31 9 NP-16.05-18.31 12 Powered by Capital Market - Live News

Vivimed Labs will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net Loss of Vivimed Labs reported to Rs 20.30 crore in the quarter ended September 2023 as against net loss of Rs 22.03 crore during the previous quarter ended September 2022. Sales declined 23.93% to Rs 33.64 crore in the quarter ended September 2023 as against Rs 44.22 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales33.6444.22 -24 OPM %-17.54-21.05 - PBDT-15.59-18.01 13 PBT-20.30-22.03 8 NP-20.30-22.03 8 Powered by Capital Market - Live News

Vivimed Labs announced that the Annual General Meeting (AGM) of the company will be held on 13 November 2023.Powered by Capital Market - Live News

Net Loss of Vivimed Labs reported to Rs 15.58 crore in the quarter ended June 2023 as against net loss of Rs 22.20 crore during the previous quarter ended June 2022. Sales declined 29.46% to Rs 35.35 crore in the quarter ended June 2023 as against Rs 50.11 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales35.3550.11 -29 OPM %-0.93-17.10 - PBDT-10.88-17.81 39 PBT-15.58-22.26 30 NP-15.58-22.20 30 Powered by Capital Market - Live News